Selectively polymerizable compositions and methods of use in vivo

Patent metadata

Field	Value
Publication number	US-10357591-B2
Application number	US-201414583708-A
Country	US
Kind code	B2
Filing date	Dec 28, 2014
Priority date	Jun 28, 2012
Publication date	Jul 23, 2019
Grant date	Jul 23, 2019

Abstract

Otologic materials and methods are provided. For example, a cell-adhesive, biodegradable hydrogel scaffold loaded with time-released drugs for repairing chronic tympanic membrane perforations is disclosed, methods of making same and administering same are provided. This hydrogel may promote vascular in-growth and epithelial cell growth of the tympanic membrane with the purpose of closing the perforation and providing a barrier between the external and middle ear. The hydrogel is initially a liquid polymer that only gels upon exposure to specific conditions, such as exposure to light. This scaffold may simultaneously induce repair of the tympanic membrane while preventing or alleviating middle ear infection, thus filling a void in current tympanic membrane perforation therapies.

First claim

What is claimed is:

1. A method of treating a perforation of the tympanic membrane comprising:
a. administering a liquid pre-polymer composition to the tympanic membrane, the pre-polymer composition comprising: at least a first polymer and a solvent, wherein the liquid pre-polymer composition is sufficiently viscous such that it can be positioned to cover the tympanic membrane perforation without falling through to the middle ear cavity both prior to administration on the tympanic membrane and prior to activation of curing into the polymer matrix and, which when activated in situ in the ear of a patient results in the liquid pre-polymer composition assembling into a polymer matrix suitable for repairing or aiding repair of a tympanic membrane perforation, and further the liquid pre-polymer composition has a viscosity of about 2800 cP or greater; and, thereafter
b. activating the liquid composition to form a polymer matrix.

2. A method according to claim 1 , wherein the liquid pre-polymer composition comprises an initiator.

3. A method according to claim 1 , wherein the liquid pre-polymer composition further comprises a therapeutic composition, and the polymer matrix has a porosity and average pore size sufficient to release the therapeutic composition over a desired time period.

4. A method according to claim 1 , wherein repairing or aiding the repair comprises assembling the liquid into a polymer matrix stiff enough to function as a scaffold on which epithelial cells of the tympanic membrane can migrate, adhere and grow.

5. A method according to claim 1 , wherein the polymer matrix is a hydrogel.

6. A method according to claim 4 , wherein the at least first polymer is chosen to result in a functionalized scaffold having a cell-binding domain for improving cell migration and adhesion.

7. A method according to claim 5 , wherein the liquid pre-polymer composition comprises an initiator which is a photoinitiator.

8. A method according to claim 7 , wherein activating comprises exposing the liquid pre-polymer composition to UV light, visible light or blue light in situ as determined by the photoinitiator.

9. A method according to claim 7 wherein the photoinitiator is chosen from: Irgacure 2959, eosin Y in conjunction with 1-vinyl-2 pyrrolidinone and triethanolamine, camphorquinone, and riboflavin 5′-monophosphate sodium salt.

10. A method according to claim 1 , wherein the at least first polymer is chosen from polyethylene glycols (PEG), polysaccharides, poly(lactic acid)s, polyurethanes, poly(propylene glycols), poly(propylene fumarate-co-ethylene glycols), poly(hydroxyethyl methacrylates), polymethyl methacrylates, polyesters, gelatins, alginates, starches, dextrans, polyvinylpyrrolidones, poly(2-acrylamido-2-methyl-1-propanesulfonic acid), polyvinyl alcohols, polypeptides, polyacrylates, agaroses, celluloses, k-carrageenans, pectins, chondroitin sulfates, proteins and derivatives and analogs thereof.

11. A method according to claim 10 , wherein the at least first polymer is chosen from PEGs, polysaccharides, and derivatives and analogs thereof.

12. A method according to claim 11 , wherein the polysaccharides are chosen from methacrylated chitosans and methacrylated hyaluronic acids.

13. A method according to claim 12 , wherein the methacrylated chitosans are at least about 40% methacrylated, and the methacrylated hyaluronic acids are at least about 30% methacrylated.

14. A method according to claim 13 , wherein the methacrylated hyaluronic acids are at least about 90% methacrylated.

15. A method according to claim 12 , wherein the at least first polymer is methacrylated chitosan, or the at least first polymer is methacrylated hyaluronic acid, or the at least first polymer is chosen from a first polymer which is a methacrylated chitosan and a second polymer which is chosen from a methacrylated hyaluronic acid and hyaluronic acid, or the at least first polymer is a first polymer which is a PEG, a second polymer and optionally a third polymer, wherein the second and third polymer are chosen from chitosans and hyaluronic acids.

16. A method according to claim 10 , wherein the at least first polymer has molecular weight ranging from about 100 to about 1,000,000 g/mol.

17. A method according to claim 16 , wherein the at least first polymer has a molecular weight ranging from about 1000 to about 4000 g/mol.

18. A method according to claim 1 , wherein the at least first polymer is a chitosan having deacylation ranging from about 0% to about 100%.

19. A method according to claim 1 , wherein the liquid pre-polymer composition has a viscosity of about 3000 cP or greater.

20. A method according to claim 1 , wherein the liquid composition further comprises a photoinitiator, and activating comprises exposing the liquid pre-polymer composition to a light source chosen from UV light, visible light, infrared light and blue light according to the photoinitiator to cause the liquid composition to assemble to form a polymer matrix.

21. A method according to claim 1 , wherein administering comprises providing a sufficient amount of liquid pre-polymer to the site of the perforation to cover the perforation.

Assignees

• The Administrators Of The Tulane Educational Fund
• Tulane Educat Fund Inc

Inventors

• Horn-Ranney Elaine
• Khoshakhlagh Parastoo
• Moore Michael
• Ranney Jesse

Classifications

• A61P27/16

  Otologicals · CPC title

• A61L27/52

  Hydrogels or hydrocolloids · CPC title

• A61L27/20 Primary

  Polysaccharides · CPC title

• A61K38/385 Primary

  Serum albumin · CPC title

• A61N5/062

  Photodynamic therapy, i.e. excitation of an agent · CPC title